Browse Items (16 total)

Objective: To identify the frequency of insurance related issues with intravenous immunoglobulin (IVIg) therapy approval for patients with autoimmune gastrointestinal dysmotility (AGID) and the outcomes of missed IVIg treatments.

Objective: To describe the serological and clinical profile of antibody positive autoimmune gastrointestinal dysmotility patients receiving IVIg

Objective: To determine if tau pathology contributes to deficits in vision by conducting behavioral tests and histology to assess visual acuity in an Alzheimer’s disease (AD) mouse model.

Output Formats

atom, dcmes-xml, json, omeka-xml, rss2